10-Q · May 4, 2026
In the first quarter of 2026, TCMD reported revenue of $75.3 million, a significant increase of 23% from $61.3 million in Q1 2025. Despite growing revenues, a net loss of $1.8 million was recorded, though this was an…
Earnings analysis · 10-Q
TCMD earnings analysis
Filed August 10, 2026 · Our reading of the company's report
The latest report
The supplied 10-Q excerpt provides no income statement, balance-sheet, cash-flow, segment, or quantitative guidance data, so operating trends cannot be assessed from the filing text provided. It does show 208,900 shares…
Read full summary
The supplied 10-Q excerpt provides no income statement, balance-sheet, cash-flow, segment, or quantitative guidance data, so operating trends cannot be assessed from the filing text provided. It does show 208,900 shares repurchased during the quarter and $18.651 million remaining under the $25.0 million authorization. Controls were effective as of June 30, 2026, and management reported no material changes to internal controls or risk factors from the December 31, 2025 disclosures.
What stood out
-
Share repurchases resumed
The company repurchased 208,900 shares during the quarter ended June 30, 2026, including 158,900 shares in April and 50,000 shares in June.
-
Meaningful buyback capacity remains
The company had $18.651 million remaining under its repurchase authorization at June 30, 2026, compared with the original program authorization of $25.0 million.
-
Disclosure controls effective
Management concluded that disclosure controls and procedures were effective at the reasonable assurance level as of June 30, 2026.
-
No material control changes
The company reported no changes during the quarter ended June 30, 2026, that materially affected or were reasonably likely to materially affect internal control over financial reporting.
What to watch
-
No updated risk-factor detail
The filing states that there were no material changes in risk factors from those disclosed in the Annual Report on Form 10-K for the year ended December 31, 2025; therefore, no new or revised risk-factor disclosures were identified.
-
Legal exposure not quantified
The filing incorporates legal-proceeding information from Note 9, Commitments and Contingencies, but the supplied excerpt does not quantify any related exposure.
-
Cash allocation from buybacks
The company repurchased 208,900 shares during the quarter, reducing the remaining authorization to $18.651 million from the $25.0 million program authorization; continued repurchases could reduce cash available for other uses.
Management's outlook
The provided 10-Q excerpt does not include quantitative revenue or EPS guidance. No forward outlook, liquidity outlook, or capital-spending forecast is disclosed in the supplied text.
Earlier filings 1
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.